Major Thalassemia, Screening or Treatment: An Economic Evaluation Study in Iran.

Firooz EsmaeilzadehBatoul AhmadiSajad VahediSaeed BarzegariSeyed Moayed Alavian

Published in: International journal of health policy and management (2021)

Screening is a long-term value for money intervention that is highly cost effective and its long-term clinical and economic benefits outweigh those of managing thalassaemia major patients.

Keyphrases

end stage renal disease
randomized controlled trial
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
replacement therapy
patient reported